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Abstract
A low-protein diet applied during pregnancy in the rat results in intrauterine growth restricted (IUGR) fetuses. In humans,
IUGR is associated with increased perinatal morbidity, higher incidence of neuro-developmental defects and increased risk
of adult metabolic anomalies, such as diabetes and cardiovascular disease. Development and function of many organs are
affected by environmental conditions such as those inducing fetal and early postnatal growth restriction. This phenomenon,
termed ‘‘fetal programming’’ has been studied unconnectedly in some organs, but very few studies (if any) have
investigated at the same time several organs, on a more comparative basis. However, it is quite probable that IUGR affects
differentially most organ systems, with possible persistent changes in gene expression. In this study we address
transcriptional alterations induced by IUGR in a multi-organ perspective, by systematic analysis of 20-days rat fetuses. We
show that (1) expressional alterations are apparently stronger in organs functioning late in foetal or postnatal life than in
organs that are functioning early (2) hierarchical classification of the deregulations put together kidney and placenta in one
cluster, liver, lungs and heart in another; (3) the epigenetic machinery is set up especially in the placenta, while its
alterations are rather mild in other organs; (4) the genes appear deregulated in chromosome clusters; (5) the altered
expression cascades varies from organ to organ, with noticeably a very significant modification of the complement and
coagulation cascades in the kidney; (6) we found a significant increase in TF binding site for HNF4 proteins specifically for
liver genes that are down-regulated in IUGR, suggesting that this decrease is achieved through the action of HNF
transcription factors, that are themselves transcriptionnally induced in the liver by IUGR (x 1.84 fold). Altogether, our study
suggests that a combination of tissue-specific mechanisms contributes to bring about tissue-driven modifications of gene
cascades. The question of these cascades being activated to adapt the organ to harsh environmental condition, or as an
endpoint consequence is still raised.
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Introduction
The period of intrauterine growth and development is one of the
most vulnerable periods in the human life cycle. The weight of the
infant at birth is a powerful predictor of infant growth and survival,
and is dependent on maternal health and nutrition during
pregnancy. Low birth weight leads to an impaired growth of the
infant with its attendant risks of a higher mortality rate, increased
morbidity [1], impaired mental development [2] and the risk of
chronic adult disease [3]. Intra-uterine growth restriction (IUGR) is
defined by a failure of the fetus to reach his/her normal (or
genetically defined) growth potential [4]. In a clinical sense, it is
therefore detectable by morphometric analysis of ultrasonographic
scans followed by the conversion of length measures (femur, radius)
to an estimation of weight [5]. The notion of SGA (Small for
Gestational Age) is defined by a birth weight below the 10
th
percentile at a given gestational age; it is actually currently used as
an approximation for IUGR; however, it mainly refers to
measurements carried out at birth, rather than to a dynamic
measure involving an in utero rupture of the growth curve. IUGR is a
very important health problem with a prevalence estimated at
,10%in the generalpopulation [6]. It leads to ,10% of the overall
perinatal mortality [7]. IUGR, especially when it is not associated to
vascular causes, obviously embraces a very heterogeneous spectrum
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understand the physiopathology of this disorder [8,9,10]. In rats, a
low birth weight can be induced in pups when dams are fed a
isocaloric low protein diet (half to one third of the normal protein
content, accordingto the studies, i.e. 8–10% versus 18–22%) during
pregnancy [11]. This model has been used in the present study,
since it is probably one of the most commonly used, and is known
for decades to induce multiple organ alterations [12,13,14]. In this
case,ithas been shownthat the offspringmayretainanatomical and
functional defects at adulthood in different organs [15]. Other
studies have shown that the number of renal glomeruli is reduced in
these pups [16] and remains low when a normal diet is given after
birth. Anatomical and physiological variables in the offspring brain
are also altered by this low protein diet, with a reduced number of
dendrites, a lower sensory cortico-cortical and thalamo-cortical
potentials, an elevated level of biogenic amines and alterations of
tryptophan metabolism [17]. Hence, the low protein diet modifies
drastically the metabolic environment of the fetus. Another interest
of this model is that it reflects actual situations in some human
culturesorharshsocio-economic situations.Today,themechanisms
inducing the various defects are imperfectly known, although they
could be basically caused by general defects in vascular architecture
[18], reducing the placental nutrient transfer [19], or targets of
placental hormones [20].
Previously, we have reported specific transcriptome alterations
in the placenta and in the kidney in a rat model of IUGR induced
by a low-protein diet of the pregnant females [10,21]. In the
present study, we carried out on the same animal material a
thorough transcriptional analysis including three additional
organs: heart, liver and lungs. We showed that each organ
(placenta, kidney, lung, liver and heart) displays a specific answer
(both in intensity and in nature) to the environmental injury
imposed to the pregnant rats. In addition, we pinpoint organ-
specific differences for genes involved in epigenetic regulation of
expression (DNA methyl-transferases, Histone deacetylases, His-
tone methyl and acetyl transferases, Chromodomain and Bromo-
domain protein-encoding) and imprinted genes. We also carried
out a per-chromosome analysis which reveals clusters of genes that
are more specifically modified by IUGR.
Our major conclusions sustain the existence of strong tissue-
specific differencesintheintensityoftranscriptional alterations. The
analysis of modified genes shows that variousorgan-dependent gene
pathways are altered and that in term of gene expression
modifications, kidney and placenta are clustered versus the three
other organs (liver, lung, heart). Genes modulating the epigenetic
status of the chromatin are systematically activated in the placenta,
while the situation is more contrasted in other organs. We show that
the intensity of the response is linked to the moment when each
organ becomes functional, i.e. the earliest being the least affected.
We propose that since stable epigenetic modifications are less
consequential in the placenta, which is transient, they are tolerated
if they can improve the response of this organ to deleterious
environmental conditions (i.e. shortage of nutrients, and especially
proteins).In the otherorgans,ourresultssuggest that transcriptional
alterations, as important as they can be, rely mainly on transient,
transcription factor-dependent deregulations. This does not discard
the possibility of targeted epigenetic alterations as have been
evidenced for IGF1 in the liver [22].
Materials and Methods
Animals
The ethical committee for animal research at Marseille Medical
University approved the experiments. The animals were kept
under standard conditions according to the recommendations for
the use of animals in experimental designs and according to the
‘‘3R’’ rules. The authorization number for the experiments is:
D13–491. The agreement of the animal facility is registered under
the number F13-055-5. Female virgin Sprague Dawley rats
(Charles Rivers, l’Abresle, France) weighing 225–250 g were used.
After mating, the presence of sperm in the vaginal smear the
following morning was designated as day 1 post-coitum. The rats
were fed either a 22% (w/w) casein (control) or a 9% (w/w) casein
(LP) diet throughout gestation, as described previously [21]. Both
diets were isocaloric, because the protein deficiency in the LP diet
was compensated by the addition of carbohydrates. During
pregnancy animals were weighed and food intake was recorded
daily. The pregnant rats about 100 days old, at their first gestation,
were euthanized following anesthesia with halothane-nitrous oxide
at gestation day 20 (20–21 days post coitum) and placentas and
fetal tissues were rapidly removed, weighed and frozen in liquid
nitrogen and stored at 280uC for later RNAs expression analysis.
The choice of sacrificing the females at 20 days was dictated by the
necessity to be sure to obtain the placentas, since the normal
gestation is 21–23 days. A total of 77 and 67 fetuses in 6 and 5
litters, respectively, were weighed for the LP diet and the control
group, respectively. Alterations in relative and absolute fetal organ
weight have been already published, see Table S3 [21]. Absolute
organ weights were in general reduced by ,20%, but the
placental weight was reduced of only 12%. Relative to body
weight, liver, heart and kidneys were still significantly reduced in
weight. Technically speaking, there is no official growth curve for
rats, then for maximizing the effects detected in the microarray
analysis, the most extreme organs in term of weights were chosen
in the control and the treated group. This way, we hypothesize
that the most drastic cases of IUGR have been considered in the
study.
RNA preparation, cDNA synthesis, and microarray
hybridizations
RNA isolation was performed according to standard protocols
using Trizol reagent and controlled (precise integrity checks and
sample quantitation) by Agilent bioanalyser 2100. Ten micro-
grams total RNA from a pool of more than 30 fetal tissues from LP
group and a pool of more 30 fetal tissues (those displaying the
larger weight reduction) for the control group were hybridized to
long oligonucleotides microarrays, at the Nimblegen platform in
Reykjavik, Iceland, following described protocols. A total of
390,000 oligonucleotides representing 23,456 transcripts from the
rat genome were hybridized with fluorescently labeled cDNAs
from each fetal tissue (LP group vs control group). Image analysis
was performed with the NimbleScan software (Nimblegen), and
feature intensities were exported as .pair files. ArrayStar 3.0
(DNASTAR, Madison, WI) was used for probe summarization
and normalization (RMA algorithm, quantile normalization),
statistical analysis of differentially expressed genes (Student’s t-test
with Benjamini-Hochberg false discovery rate correction) and
gene ontology analysis. The entire microarray data set is available
at the Gene Expression Omnibus (accession nu GSE25764).
Quantitative Real-Time RT-PCR
Total RNA was treated with DNAse. DNAse was inactivated
and cDNA synthesis was performed using the MMLV cDNA
synthesis kit (Invitrogen, Carlsbad, CA). Mix preparation and
PCR amplification were performed according to standardized
protocols using PlatinumH Quantitative PCR MasterMix (Invitro-
gen, Carlsbad, CA) and Light Cycler (Roche, Indianapolis, IN)
respectively. PCR oligonucleotides were chosen using PRIMER3
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coding sequence of each gene of interest and generally overlapping
two consecutive exons. The different couples were aligned against
the rat genome using BLAST to check their specificity. 18S
mRNA amplified from the same samples served as an internal
control. Quantitative PCR was carried out from 2 mlo fa1 0ml
dilution of the cDNA in a volume of 17 ml using a LightCycler
thermocycler (Roche, Indianapolis, IN). The master mix SYBR
Green from Invitrogen was complemented with MgCl2 (4 mM
final concentration), BSA (0.05 g/l) and primers 10 mM). The
PCR program was as follows: 50C 120s, 95C for 120 s, 35 cycles of
94uC for 5 s, 58uC for 10s and 72uC for 30 s, followed by 65uC for
15 s and a raise in temperature to 99uC at 0.1uC /s. This last step
was used to generate fusion curves. The specificity of the PCR
products was verified by melting curve analyses and agarose gel
electrophoresis, as previously described [23]. Ct values were
calculated with LightCycler Software and The Ct values of the
gene of interest were normalized by the Ct value obtained for the
18S gene taken as a reporter gene, using the 2-DDCt approach as
outlined by Livak and Schmittgen [24].
Microarray analysis
Non-supervised clustering analysis was performed using Cluster
[25] and JavaTreeview [26]. This analysis clusterized reliably the
duplicates of each hybridization and also the various organs either
from growth-restricted or normal newborns (Figure S6), marking
the good technical quality of the data obtained and analyzed
throughout this study. Pathway analysis was carried out using the
GePS tool of the Genomatix portal (http://www.genomatix.de/
en/index.html). Table of genes modified more than twice were
submitted as text files with the level of induction/repression. This
made it possible to generate pathways with a threshold for
significance in the gene clustering established at p,0.01.
Promoter analysis
Promoters were recovered using the Genomatix
TM software
and database. Predicted transcription factor binding sites were
identified and counted. Statistical analysis was performed by the
comparison of induced and repressed genes using a Student t-test
corrected for multiple testing.
Statistical analysis for abnormal representation of groups
of genes
When groups of genes (epigenetic regulator, imprinted genes,
per chromosome genes) were analyzed they were compared to the
rest of the genome using a x2 contingency test. Difference were
considered significant when p,0.05.
Results
1. Organ-specific intensity of the effects of growth
restriction
An estimation of the intensity of the transcriptional alterations
was made using a similar threshold fixed at two folds throughout
the complete study, starting from the 23456 transcripts that were
present in the microarray (Figure 1). The microarray data were
validated by qRT-PCR for a series of 12 genes in lungs and
liver and 11 genes in heart, as shown in Figure S1; the expre-
ssion value for the q-RT PCR are the average of four indepen-
dent experiments carried out on pools of cDNA. The validation
for placenta and kidney was previously published [21]. The
correlation between the microarray and the qRT-PCR was .0.95,
while the determination coefficient was in all cases.0.8.
We could classify the organs relatively to the percentage of
modified genes. In the lungs, it reached ,34%, ,24% in the
placenta and liver, ,7.7% in kidneys and only 3.3% in the heart.
Only the placental gene expressions were not deviated towards
up- or down regulation (p=0.39), while it appeared that lung,
kidney and heart presented an increased number of down-
regulated genes (p,2.7 10
217, ,1.5 10
210, ,1.2 10
24, respec-
tively). By contrast, the liver presented an excess of up-regulated
transcripts (,2.1 10
25).
2. Clustering of the effects reveals a dichotomy in organ
response to stress
Non-supervised hierarchical clustering was performed from the
correlation coefficients calculated between the different organs and
two clusters were separated, one including placenta and kidney,
and the other including heart, lung and liver (Figure 2). The
cophenetic correlation, which grossly measures the robustness of
the tree was of 0.993 (p value=1.3 10
28). This inverse correlation
is illustrated in Table 1, for instance between placenta and lung.
Statistically the number of genes that should be over-expressed
more than twofold in both these tissues was estimated at 442 (grey
part under the diagonal), while the actual number of genes in this
situation was only 26. Reciprocally, the number of genes that
should be reduced more than twofold in both tissues is estimated at
561, while the actual number is only 125. By contrast, the number
of genes that should be induced more than two-fold in the placenta
and reduced more than two-fold in the lung can be estimated at
536, while the actual number of genes in this situation is actually
1556; finally, in the reciprocal case (induced more than two-fold in
lungs and reduced to the same extent in the placenta), the
estimated number of genes is 462 while the actual value is 820.
Thus, but some rare exceptions, the use of thresholds yielded the
same type of results than the global correlation analysis, and
confirmed the grouping in two categories of expressional response
to induced IUGR, one of the kidney/placenta type and one of the
liver/lung/heart type.
3. Analysis of specific groups of genes
We then used our dataset to investigate the impact of the
applied nutritional stress on genes susceptible to carry at least
partly a ‘memory’ of the modifications, namely epigenetic
regulator genes, taken in a broad sense and imprinted genes. We
also performed a chromosome-based analysis in order to detect
possible biases in deregulation according to the chromosome
analyzed, susceptible to occur according to previous results [27].
a. Epigenetic regulators.. We investigated five groups of
genes, encoding DNA methyltransferases, Histone Deacetylases,
Histone methyl- and acetyl-transferase, Bromodomain-containing
proteins recognizing acetylated lysine residues in particular in
histone tails [28], and Chromodomain-containing proteins
recognizes methylated histones [29] and appears in the RISC
complex [30]. These proteins are important epigenetic regulators
associated either with opened chromatin or closed chromatin for
bromodomains and chromodomains, respectively. The complete
list of genes analyzed is given as Table S1.
The results are summarized in Table 2 and Figure 3. DNMTs
were overall down-regulated exclusively in the liver (p=0.00011)
while HDACs are generally down-regulated genes in the lungs. No
significant values were seen for genes encoding bromodomain- or
chromodomain- containing proteins, or for histone either acetyl-
or methyl- transferases. However, when all the categories were
taken together, the statistical tests were significant for the lung and
for the placenta. In this latter organ, the expression of genes
encoding epigenetic modulators could never be found reduced,
Differential Impact of IUGR on Fetal Organs
PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21222Figure 1. Alterations of the transcriptome in the five organs analyzed in this study. mRNA transcripts that are increased in Intra-Uterine
Growth Restriction are represented in green, decreased transcripts are in red. The chosen threshold is 2-fold, as described in the text. There appears
to be a biased excess in decreased transcripts in lungs, kidney and heart, a biased excess of increased transcripts in the liver, no significant difference
in the placenta (see text).
doi:10.1371/journal.pone.0021222.g001
Figure 2. Non-supervised clustering of correlations between tissues categorized placenta and kidney into one group, while liver,
lung and heart are into another group. This is due to the fact that the transcriptional response to IUGR is often opposite between the two
groups of organs. This is illustrated in more details in Table 1.
doi:10.1371/journal.pone.0021222.g002
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Up-regulated Down-regulated
Lung Liver Kidney Heart Placenta Lung Liver Kidney Heart Placenta
Up-regulated Lung 3642 1987 20 256 26 0 43 688 16 1556
Liver 459 2956 12 246 151 557 0 614 43 1091
Kidney 120 97 772 2 164 145 86 0 22 28
Heart 53 43 11 343 1 65 38 15 0 133
Placenta 442 358 94 42 2844 536 316 126 56 0
Down-regulated Lung 0 77 261 6 820 4418 1219 24 170 125
Liver 405 0 258 6 353 491 2607 14 109 163
Kidney 161 131 0 123 0 196 116 1040 8 733
Heart 72 58 15 0 38 87 51 21 463 42
Placenta 462 375 98 44 0 561 331 132 59 2978
The small numbers, below the diagonals corresponds to the expected number of genes, calculated according to a contingency table, bold or italics mark an excess or
deficit in the number of genes actually counted in each category, respectively.
doi:10.1371/journal.pone.0021222.t001
Table 2. Number of genes involved in epigenetic regulation by tissue and by category in IUGR rats.
All genes Lung Liver Kidney Heart Placenta
x2 Lung
(p value)
x2 Liver
(p value)
x2 Kidney
(p value)
x2 Heart
(p value)
x2 Placenta
(p value)
Up-regulated 3642 2950 772 343 2844
Down-regulated 4418 2607 1040 463 2978
Unchanged 15396 17899 21644 22650 17634
DNMTs Lung Liver Kidney Heart Placenta 0.5337 0.0001 0.6861 0.0949 0.5028
Up-regulated 1 1 0 0 1
Down-regulated 3 5 0 0 0
Unchanged 5 3 9 9 8
HDACs Lung Liver Kidney Heart Placenta 0.0367 0.2921 0.5565 0.8520 0.2664
Up-regulated 0 0 0 0 1
Down-regulated 6 1 0 0 0
Unchanged 8 13 14 14 13
CHDs Lung Liver Kidney Heart Placenta 0.9366 0.0754 0.5119 0.7795 0.1215
Up-regulated 3 5 0 1 4
Down-regulated 3 1 0 0 0
Unchanged 10 10 16 15 12
BRDs Lung Liver Kidney Heart Placenta 0.3832 0.2676 0.4708 0.2430 0.1486
Up-regulated 1 0 0 0 4
Down-regulated 5 2 0 0 0
Unchanged 12 16 18 18 14
Histone Methyl/acetyl
transferases
Lung Liver Kidney Heart Placenta 0.3222 0.2457 0.6051 0.7260 0.3998
Up-regulated 0 3 0 0 2
Down-regulated 3 0 0 0 0
Unchanged 9 9 12 12 10
All epigenetic
effectors
Lung Liver Kidney Heart Placenta 0.0328 0.8633 0.0557 0.4990 0.0044
Up-regulated 5 9 0 1 12
Down-regulated 20 9 0 0 0
Unchanged 44 51 69 68 57
Significant p values, calculated by a x2 contingency test are indicated in bold characters. The numbers represent the count of modified and not modified genes for each
category and each tissue analyzed (see also figure 1).
doi:10.1371/journal.pone.0021222.t002
Differential Impact of IUGR on Fetal Organs
PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e21222meaning that seemingly, the epigenetic machinery is fully activated
in this organ, emphasizing its major role as an interface between
the stressful environment and the foetus.
Interestingly, Dnmt3a and 3b are strongly downregulated in the
lungs (211.3 and 23.14 fold respectively), suggesting an overall
unability of this organ to de novo methylate CpG islands. In
addition, in lungs, genes involved in the monocarbon and
glutathione metabolism pathways were almost systematically
down-regulated. In particular we found that Betaine homocystein
methyltransferase (BHMT), cystathionase (CTH), cysteine sulfinic
acid decarboxylase (CSAD), methionin synthase (MTR), cystathi-
onine beta synthase (CBS), Serine hydroxymethyltransferase1
(SHMT1), dihydrofolate reductase (DHFR) were reduced 23,
21.8, 23 21.9, 22.4, 23.3, 21.9 and 22 fold respectively. This
suggests that the availability of methyl residues may be limited in
the lungs. Together with the overall downregulation of DNMTs,
this indicates that de novo DNA methylation is probably quite
limited in the lungs. This does not eliminate the possibility of a
passive demethylation affecting all the genome in this organ, with
possible long-term consequences. We observed the inverse
tendency for these genes in the placenta (data not shown). It is
interesting to notice that alterations are not directly linked to the
generation of an ‘opened’ or ‘closed’ state of the chromatin.
b. Imprinted genes. Several imprinted genes have been
shown to be altered at the expression level following embryo
manipulation and placental diseases [27,31] prompting us to
analyze them specifically. Known imprinted genes were recovered
from the Otago catalogue [32], at http://igc.otago.ac.nz/home.
Figure 3. Genes modulating epigenetic modifications of the chromatin are differentially altered according to the tissue under
scrutiny. The list of transcripts analyzed is given as Table S1. Note that in the placenta, all these effectors are up-regulated, while the trends tends to
be opposite in the lungs. These alterations are not strictly correlated with an ‘opened’ or a ‘closed’ chromatin; for instance, the up-regulation of
histone transferases genes in the liver concerns acetyl- and methyl-transferases, altogether.
doi:10.1371/journal.pone.0021222.g003
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mouse list was used to screen the Nimblegen
TM rat array. A total
of 83 transcripts was obtained (Table S2).
The results of the comparison between imprinted genes and the
rest of the genome is presented in Figure 4. Statistical analyses by
x2 tests showed a significant deviation only for the kidney, where
up-regulated genes were in excess compared to the rest of the
genome, while down-regulated were on the contrary in lower than
expected number (p=0.024). In this organ, the down-regulated
genes were Dlk1 and Dmd (3 fold and 2 fold, respectively), while the
up regulated genes were Mest, Gnas, Ndn, Sfmbt2, Apoe, Th and Nnat,
induced 2.1, 2.6, 2.8, 3.5, 3.9, 3.9 and 4.6 fold, respectively. In the
placenta, if the genes are divided into two classes (reduced more
than twice and the rest), the p value is 0.031, suggesting that
overall, there is a deficit in down-regulated imprinted genes in the
IUGR placenta at term. This is reminiscent of the effects of In
vitro Fertilization techniques applied to mouse blastocyst, which
triggers a selective activation of the expression of imprinted genes
[27].
c. Chromosome-specific alterations of gene
expression. We analyzed the effects of low protein maternal
diet induced-IUGR in the rat model on a chromosome per
chromosome basis, to identify possible bias in abnormal gene
expression (Table 3 and Figure 5). After Bonferronni correction for
multiple testing there appears a bias in 18 cases, half of these cases
concern the placenta. The strongest biases were found for
chromosome 15, for the Placenta and the Kidney. In these
organs, the explanation for the discrepancy resides in the
concentration of clusters of deregulated genes (Figure 6). As
shown in the figure, which is drawn after a smoothing using a
sliding window of 10 consecutive genes, the discrepancy with the
rest of the genome is mainly due to the existence of four
consecutive regions (A, B, C and D on Figure 6). The down-
regulated genes behave in a strikingly similar way between the
Figure 4. Comparison of the deregulations of known imprinted genes with the genomic alterations, 83 transcripts obtained from
the Otago database http://igc.otago.ac.nz/home.html. The color code is the same than the other figures for the pan-genomic alterations, blue and
yellow were added for imprinted genes when they are induced or repressed, respectively. The existence of significant discrepancies between
imprinted genes and the rest of the genome especially in the kidney and to a lesser extent in the placenta is discussed in the text.
doi:10.1371/journal.pone.0021222.g004
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regulation might be at work in placental and renal tissue, as
suggested by the hierarchical classification. The first cluster (A) of
down-regulated genes is located between 4.6 and 6.3 megabases
on chromosome 15. It encompasses genes of the Spetex family
(essentially known to be involved in spermatogenesis) that
probably share regulatory sequences in their promoters. The
second region (B) is located between 19.3 and 20.6 megabases and
encompasses a second cluster of genes of the Spetex family. The
third cluster maps between 27.0 and 35.3 megabases, and can be
in fact subdivided into a series of three gene clusters; the first (27–
27.2) is composed of a series of Rnases and of the two angiogenins
(Ang1 and Ang2), that are all under-expressed in the placenta; the
second (27.9–30.8) encompasses genes of the T-cell receptor
family; the third (34.1–35.3) encompasses a cluster of genes of the
mast cell protease family, immediately followed by a series of
granzyme-encoding genes. Overall, the level of deregulation is
much higher in the placenta. To illustrate the existence of a
‘‘mirror’’ regulation of lung and liver compared to kidney and
placenta, lung deregulations were represented on the figure for the
lung, even though these are not different from the rest of the
genome for this specific organ. While some clusters are really in
mirror, such as clusters A and B, it clearly appears that lung-
specific deregulations exist, such as a long series of up-regulated
genes spanning from 75 to 80 Megabases on Chr 15. In this
specific case, however, the region is spanning the centromere and
contains very few genes (only 28 on 20 Mb), the apparent up-
regulation being the result of a limited number of very strongly up-
regulated genes in the region, that gives this impression.
4. Pathway analysis using GePS (Genomatix
TM)
Using Genomatix GePS, we searched for pathways significantly
enriched in modified genes in the different organs under scrutiny.
The exhaustive discussion of these pathways is given as Material
S1. The most striking observations are the identification of the
VEGFR1 pathway in the placenta (Figures S2A and S2B; note,
colors in Figures S2, S3, S4 and S5 correspond to up-regulated
genes in red and according to the intensity, and blue for down-
regulated genes), of coagulation cascades in the kidney, confirming
with novel analysis tools the pathways previously observed [21]
(Table 4A), of FOXA transcription factor regulation in the heart,
BAD signaling in the lungs (Table 4 B) and PKA signaling in the
liver.
The activation of VEGF-associated cascades in the IUGR
placenta, suggests an attempt toward at least a compensation of
the shortage in nutrients by an improved vascularisation of the
placenta. In the IUGR kidney, the intrinsic prothrombin pathway
is shown (Figure 7); numerous coagulation factors are consistently
up-regulated, demonstrating a severe alteration of this pro-
coagulation cascade, and suggesting an increased risk of
thrombosis and clotting. The induction levels ranged from 2.2
for COL genes to ,6–7 fold for Kallikrein 1 and FGA.
5. Promoter analysis
In an attempt to identify master genes of the IUGR-induced
deregulations, we proceed to an analysis of the predicted binding
sites for transcription factors present in genes oppositely altered.
The occurrence of binding sites for transcription factors was
obtained from the Matinspector Genomatix software for the
Table 3. Distribution biases of deregulated gene broken down per chromosome after Bonferronni correction.
Lung Liver Kidney Heart Placenta
Chr1 0,93719715 27,7616851 16,9094284 50,9431964 5,8001E-07
Chr2 0,56963298 24,4103093 0,00528531 4,35429977 5,7061E-12
Chr3 57,592184 86,0966746 1,0359E-06 56,5107586 0,65191661
Chr4 8,79755304 7,33832422 32,2382249 97,7573529 15,8225724
Chr5 21,2714321 49,1904907 99,3886778 36,5643412 28,4298196
Chr6 39,9012864 19,1931742 25,0329042 103,759756 0,00398762
Chr7 0,03372224 46,6923504 29,3933753 91,6593564 0,69234961
Chr8 18,0181441 8,79806359 21,1989756 12,4593178 68,3992631
Chr9 93,3072846 86,9995348 30,7128232 20,2238963 6,3430038
Chr10 0,07739599 0,00747273 2,70908847 80,9597416 0,00345094
Chr11 98,310212 64,5104577 28,7471647 23,6581667 0,00337356
Chr12 40,7190874 22,4247406 7,71631187 69,3864974 0,00063281
Chr13 13,9540592 12,1852239 0,23267013 59,2385059 2,04433468
Chr14 22,9582733 78,0615511 70,8415389 104,143738 5,98657976
Chr15 3,82645274 29,0830732 7,4459E-20 6,61142125 4,8548E-23
Chr16 57,4235089 27,6180086 18,4202361 96,8714551 15,9626296
Chr17 0,02793192 3,4775979 28,8720671 17,2061379 8,56081387
Chr18 37,8838928 35,6738566 70,0097025 81,2997108 0,44847596
Chr19 0,55972949 57,1658765 52,5183901 23,7079137 37,0946765
Chr20 1,1811E-05 0,02251991 1,1301E-09 69,0101162 3,2653E-05
ChrX 0,08333262 80,2258047 12,7409338 0,13210437 0,00236127
Significant p values, calculated by a x2 contingency test are indicated in bold at the threshold of 0.05 after Bonferronni correction for multiple testing. The numbers
represent the p value times the number of tests performed, which explains why some values are above 1.
doi:10.1371/journal.pone.0021222.t003
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modified genes were observed, especially for 12 chromosomes, and are much more abundant in the placenta than in other organs (9 chromosomes
affected amongst 21). It is interesting to notice that while there is as many deregulations in the liver as in the placenta, no such chromosomal
grouping could be observed, since in this organ, only chromosomes 10 and 20 contains clusters of deregulated genes, detected with a moderate
level of significance (** and *, respectively). In the heart, no chromosome-specific cluster of deregulated genes could be observed. Asterisks represent
significance thresholds (*: ,0.05, **: ,0.01, and ***: ,0.001). Tests were performed using a c2 contingency test followed by a Bonferronni correction
for multiple testing (actual values are listed in Table 3).
doi:10.1371/journal.pone.0021222.g005
Figure 6. Profile of gene expression deregulation for three organs on chromosome 15. We coud identify four windows where gene
expression dergulations were opposed between lungs (blue line) on the one hand and kidney-placenta in the other hand (red and green line,
respectively). Deregulations are represented as the average of log2(gene induction ratios), on windows of ten consecutive genes. Four regions named
A, B, C and D are analyzed in the text in terms of gene content.
doi:10.1371/journal.pone.0021222.g006
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PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e21222Table 4. Genes modified and clustered by Genomatix in pathways in the kidney and in the lung, with highly significant p-values.
Kidney Canonical
pathways
Pathway
id P-value
Adjusted
p-value
# Genes
(observed)
# Genes
(expected)
# Genes
(total) List of observed genes
intrinsic
prothrombin
activation pathway
BioCarta:
intrinsic
pathway
4,62E-13 n/a 12 0.712 24 KNG1, FGG, F12, F11,
PROC, F13B, F10, FGB,
F2, F9, FGA, KLKB1
extrinsic
prothrombin
activation pathway
BioCarta:
extrinsic
pathway
1,16E-09 n/a 8 0.415 14 FGG, PROC, F13B, F10,
FGB, F2, TFPI, FGA
fibrinolysis
pathway
BioCarta:
fibrinolysis
pathway
1,49E-07 n/a 7 0.475 16 FGG, PLG, F13B,
FGB, F2, FGA, CPB2
classical
complement
pathway
BioCarta:
classic
pathway
1,01E-03 n/a 4 0.475 16 C5, C8A, C1QC, C9
alternative
complement
pathway
BioCarta:
alternative
pathway
2,61E-03 n/a 3 0.297 10 C5, C8A, C9
platelet amyloid
precursor protein
pathway
BioCarta:
plateletapp
pathway
5,84E-03 n/a 3 0.386 13 PLG, F2, F9
lectin induced
complement
pathway
BioCarta:
lectin
pathway
7,27E-03 n/a 3 0.416 14 C5, C8A, C9
mechanism of
gene regulation
by peroxisome
proliferators via
ppara
BioCarta:
ppara
pathway
7,39E-03 n/a 5 1.247 42 EHHADH, FABP1,
APOA2, LPL, PPARA
Lung Canonical
pathways
Pathway
id P-value
Adjusted
p-value
# Genes
(observed)
# Genes
(expected)
# Genes
(total) List of observed genes
AKT(PKB)-Bad
signaling
INOH:EPO_
signaling
1,49E-05 n/a 61 37.28 178 RPS6KA2, EPO, ACVR1B,
BRAF, IRAK4, MAP3K10,
PDGFRB, PRKCI, STAT3,
RPS6KB2, GFRA1, MAPK8,
PRKCZ, ACVRL1, MAP2K1,
PIK3CB, PRKCE, PRKCQ,
JAK1, KIAA1804, EGFR,
MET, IKBKE, BTK, MAPK12,
MAP2K7, STAT5A, NTRK1,
MAP4K2, RIPK3, SYK,
MAPK13, PTK2B, TEC,
CSNK1G3, INSR, PRKCG,
FGFR3, ADRBK1, PRKCD,
PIK3CD, CDK6, PLK3,
MAP3K11, FLT4, MAP3K12,
GRK4, FGFR1, CAMK2B,
PIK3R2, FGFR4, ARAF,
ACVR2B, EPOR, MAP3K5,
CCNH, FYN, SRC, MAP3K14,
MAP3K2, CSNK1G2
IL-7 signaling
pathway
(JAK1 JAK3
STAT5)
INOH:IL-7_
signaling
5,29E-05 n/a 59 37.07 177 RPS6KA2, ACVR1B, BRAF,
IRAK4, MAP3K10, PDGFRB,
PRKCI, RPS6KB2, GFRA1,
MAPK8, PRKCZ, ACVRL1,
MAP2K1, PIK3CB, PRKCE,
PRKCQ, JAK1, KIAA1804,
EGFR, MET, IKBKE, BTK,
MAPK12, MAP2K7, STAT5A,
NTRK1, MAP4K2, RIPK3, SYK,
MAPK13, PTK2B, TEC,
CSNK1G3, INSR, PRKCG,
FGFR3, ADRBK1, PRKCD,
PIK3CD, CDK6, PLK3, MAP3K11,
FLT4, MAP3K12, GRK4, FGFR1,
IL7R, CAMK2B, PIK3R2, FGFR4,
ARAF, ACVR2B, MAP3K5, CCNH,
FYN, SRC, MAP3K14,
MAP3K2, CSNK1G2
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pathways
Pathway
id P-value
Adjusted
p-value
# Genes
(observed)
# Genes
(expected)
# Genes
(total) List of observed genes
Migration INOH:VEGF 9,14E-05 n/a 59 37.70 180 ELK1, RPS6KA2, ACVR1B, BRAF,
IRAK4, MAP3K10, PDGFRB,
PRKCI, RPS6KB2, GFRA1, MAPK8,
PRKCZ, ACVRL1, MAP2K1, PIK3CB,
PRKCE, PRKCQ, JAK1, KIAA1804,
EGFR, MET, IKBKE, BTK, MAPK12,
MAP2K7, NTRK1, MAP4K2, RIPK3,
SYK, MAPK13, ITPR3, PTK2B, TEC,
CSNK1G3, INSR, PRKCG, FGFR3,
ADRBK1, PRKCD, PIK3CD, CDK6,
PLK3, MAP3K11, FLT4, MAP3K12,
GRK4, FGFR1, CAMK2B, FGFR4,
ARAF, PLCG2, ACVR2B, MAP3K5,
CCNH, FYN, SRC, MAP3K14,
MAP3K2, CSNK1G2
Heterotrimeric
GPCR signaling
pathway (through
glutamate, G
alpha q and
PLC beta)
INOH:GPCR_
GroupI_
metabotropic_
glutamate_
receptor
1,35E-04 n/a 15 5.86 28 GRM5, BRAF, PRKCI, PRKCZ,
PLCB2, MAP2K1, PRKCE, PLCB1,
PRKCQ, PLCB3, ITPR3, PRKCG,
PRKCD, GNB3, ARAF
Cytokine
receptor
degradation
signaling
INOH:JAK_
STAT_
pathway_
and_
regulation
5,77E-04 n/a 79 56.97 272 IL13, RPS6KA2, EPO, IL12A,
ACVR1B, BRAF, IRAK4, MAP3K10,
IL1RAP, PDGFRB, PRKCI, PTPN6,
STAT3, RPS6KB2, IFNA7, GFRA1,
MAPK8, PRKCZ, IL6R, ACVRL1,
MAP2K1, TNF, PRKCE, CSF3R,
PRKCQ, SOCS7, JAK1, KIAA1804,
EGFR, MET, PRLR, IKBKE, IL12RB2,
BTK, TNFSF10, MAPK12, CSF3,
MAP2K7, STAT5A, IL6ST, NTRK1,
IL12RB1, MAP4K2, RIPK3, SYK,
MAPK13, PTK2B, TEC, CSNK1G3,
INSR, PRKCG, FGFR3, ADRBK1,
PRKCD, CDK6, PLK3, MAP3K11,
FLT4, MAP3K12, GRK4, FGFR1,
IL7R, CAMK2B, FGFR4, ARAF, IL9,
ACVR2B, LTA, EPOR, MAP3K5,
CCNH, FYN, SRC, MAP3K14,
MAP3K2, MPL, CSNK1G2,
IFNAR1, GRB2
Thromboxane A2
receptor signaling
NCI-nature:
txa2pathway
1,38E-03 n/a 21 11,100894 53 EGF, PRKCZ, ICAM1, PLCB2,
PRKCE, PRKCQ, BLK, GNA12,
NOS3, EGFR, GNA11, ARHGEF1,
SELE, SYK, PRKCG, ADRBK1,
PRKCD, HCK, FYN, SRC, FGR
amb2
Integrin
signaling
NCI-nature:
amb2_
neutrophils_
pathway
2,71E-03 n/a 20 10,89144317 52 MMP2, SELPLG, PRKCZ, ICAM1,
JAM3, TNF, THY1, CTGF, PLAU,
BLK, MST1R, PLG, APOB, LRP1,
ITGB2, MMP9, HCK, FYN, SRC,
FGR
basic mechanism of
action of ppara
pparb(d) and pparg
and effects on
gene expression
BioCarta:
pparpathway
7,56E-03 n/a 4 1,047254151 5 PTGS1, PPARG, PPARA, PPARD
HIV-1 Nef: Negative
effector of Fas and
TNF-alpha
NCI-nature:
hivnefpathway
7,70E-03 n/a 14 7,330779055 35 RELA, BIRC3, MAPK8, CASP2,
TNF, CASP9, FAS, MAP2K7,
DFFB, CD247, BID, CFLAR,
MAP3K5, MAP3K14
Significant p values for the most significant cluster of genes were given by GePS (Genomatix). The p value is calculated by comparing the actual number of modified
genes observed in the arrays with the expected count from the total number of genes present in a given biological function. Significant values reflect a strong
enrichment.
doi:10.1371/journal.pone.0021222.t004
Table 4. Cont.
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Then a Student T-test analysis was carried out to compare the
occurrences, after Bonferronni correction for multiple testing as
already described for placenta and kidney [10,21]. Significant
differences in the occurrence of putative transcription factor
binding sites were found only in the liver for NR2F, KLFS and
PAX5 (Figure 8). We checked the transcriptome data for NR2F
binding factors expression (HNF4A, HNF4G, NR2C, NR2F) and
for KLFS binding factors (KLF proteins), and could show that
KLF4, 5, 7 are expressed at an intermediate level in the liver and
are down-regulated 2 to 3 fold by IUGR, suggesting that a
decrease level of specific KLFs could participate in the reduced
expression level of down-regulated genes. HNF4A and HNF4G
are induced 1.83 and 1.84. It could be that these transcription
factors play a negative regulatory action on the promoters of the
down-regulated genes. This could be consistent with recent data
showing that repressive function of HNF4 proteins is achieved
with specific co-repressors [33].
Discussion
Intra-Uterine Growth Restriction is a major health problem in
humans, combining risks for the baby and contributing to an
increased susceptibility to adult systemic diseases by the birth of
low birth weight newborns [34]. IUGR is multifactorial, but
animal models reproducing several aspects of the disease, have
been developed to analyze the underlying biological and cellular
defects [35]. Taking advantage of high-throughput technologies is
an efficient way of getting a full vision of the consequences of this
disease [21], but today these approaches focused specifically on
one organ [36]. To the best of our knowledge, our study is the first
that addresses abnormal expression profiles in IUGR simulta-
neously in different tissues of embryonic and extra-embryonic
origin and documents thoroughly these alterations, in a diet-
induced model of fetal growth restriction. Additional studies on
other tissues that can be important for programming later
consequences on health, would be of great interest but were not
treated in the present study. In the future in particular, analyzing
pancreas islets would be an interesting perspective, since reduction
in their size caused by IUGR have been associated with the
development of type 2 diabetes [37,38]. In addition, it has been
shown recently that these anomalies are associated with specific
epigenetic signatures involving abnormal methylation of specific
promoter sequences [39]. It could be also interesting to extend our
study to fat tissue, and in this case to distinguish subcutaneous fat
from perivascular fat that behaves differently in terms of gene
expression [40]. Nevertheless our study allows drawing specific
conclusions.
The major conclusions of our work are that organs do not react
similarly to protein depletion that induces Intra-Uterine Growth
Restriction. This is true both concerning the intensity of the
deregulations that varies on a range of 10 fold (from 3.3% of genes
modified at the threshold of 2 in the heart to 34% in the lung), and
for the profile of the responses that places placenta and kidney in
one group, while liver, lungs and heart are in another group
showing that two organs that respond similarly may have large
variations in the intensity of the response, while two organs that
respond oppositely such as liver and placenta, may have a similar
number of modified genes. Our data may thus suggest that the
long-term effects and severity of protein restriction could vary
according to the organs, some being more sensitive targets.
Interestingly also, long-term consequences of low birth weight are
not clearly described for the heart (while they are demonstrated for
the vascular system); the long-term effects on the kidney may
rather be due to a deficiency in glomerular number than
specifically to transcriptional alterations. The strong effect on the
liver is consistent with the metabolic syndrome, while lung
dysfunction in adults is not thoroughly documented for small
birth weight babies [41], although a mild effect has been described
in one study [42] . There does not appear to be a link between the
embryonic origin of the tissues and the sense (or intensity) of the
transcriptional alterations; for instance kidney and heart that are
both of mesodermal origins are clustered in different groups.
Coming back to the embryology of organ function, we searched
for correlations between developmental chronology and IUGR-
induced expression alterations. Liver developmental timing was
studied by Godlewski and coworkers using the Carnegie stages
reference. The study showed that liver becomes functional from
stage 18-23 [43]. Heart starts to function 21 days post-conception
in humans, corresponding to Carnegie stages 9–10, kidney
Figure 7. An example of pathway significantly enriched in genes modified by intra-uterine Growth-restriction in the kidney, the
intrinsic pro-thrombin activation pathways. The list of genes with their induction levels were submitted to GePS (Genomatix
TM). Genes that are
up-regulated are in red, according to the level of modification, no down-regulated genes could be identified in this pathway. Note the systematic
induction of fibrinogen peptids (fibrinogen A, B and C). The overall effects of the activation of this cascade should be to induce renal clotting and
coagulation, and thus to perturb kidney function and organogenesis, especially if there is a lesion.
doi:10.1371/journal.pone.0021222.g007
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gestation in mice (26 days in humans) but will be completed only
14–17 days post-birth. Renal function nevertheless starts from the
4th week of gestation (Carnegie stage 10–11). When kidneys are
formed, the liver is only present as a bud. Lungs start obviously to
function postnatally and alveolisation goes on up to the third
postnatal week in rats. In sum, we can conclude that for embryonic
structures, the intensity of the transcriptional alterations is
apparently strongly associated with the developmental timing of
each studied organ, and closely depends on its function, rather
than on its development. When an organ is set up at an early stage,
such as the heart, its transcriptional suppleness is drastically
limited, while when its function is delayed, such as the lungs,
intense transcriptional modifications can occur. In our study, we
also address the important question of the permanence of these
alterations in adult life which could be stabilized by epigenetic
modifications, known to occur for instance in the cord blood [44],
or the placenta [23,45,46]. It is important to notice that the
placenta as a transitory structure may accumulate adaptive
epigenetic modifications that will not have any consequence on
adult life. For permanent organs, such as the liver it may be
possible that epigenetic alterations apply, but on a strictly limited
range of gene targets; overall, in this organ it appears that DNA
methyltransferases are reduced, and our results comforts the data
of Lillycrop and coworkers on this organ showing a reduced
expression of hepatic DNMT1 in rats originating from a low
protein diet given to their mothers [47]. Feeding a low-protein diet
to pregnant rats causes hypertension and endothelial dysfunction
in the offspring [48,49]. These alterations are accompanied by
metabolic and gene expression changes, including overexpression
of the hepatic glucocorticoid and PPara receptors, and epigenetic
changes that facilitate transcription of these receptors: For the
glucocorticoid receptor, these changes include histone modifica-
tions as shown in a model of IUGR obtained by bilateral uterine
ligation [50]. IUGR has also been shown to down-regulate
DNMT1 expression in the rat brain [51]. Epigenetic control of
gene expression mediated by cytosine methylation in DNA,
histone modifications, and chromatin remodelling plays a critical
role in proliferation, cell cycle withdrawal, and terminal
differentiation [52]. DNA methyltransferases and their isoforms
are expressed in a tissue- or cell-type-specific manner which
suggests their participation in distinct developmental or differen-
tiation process. In the liver, and to a lesser extent in lungs,
DNMT3a and DNMT3b mRNA were reduced. Since these
enzymes are crucial for de novo methylation [53] it suggests that
this decrease could protect these organs from accumulating
unwanted epigenetic modifications that could be triggered by
environmental harshness, despite a strong deregulation of gene
expression. These alterations would not be durably recorded,
however, this observation does not preclude the possibility of a
Figure 8. Promoter composition analysis in the various organs suggests an increased occurrence of putative binding sites for the
transcription factor NR2F in promoters of genes down-regulated in IUGR. Promoter regions were collected (all the alternative promoters
with defined Transcription Start Sites) using the Genomatix option Gene2Promoter for the 20 most induced and 20 most repressed genes. Each dot
corresponds to a promoter. In ordinates are the numbers of putative binding sites for NR2F, and in abcissae the log2 of the induction ratio for each
promoter analyzed. Since one gene has generally several promoters, a unique induction ratio was considered for these promoters for the sake of
simplicity.
doi:10.1371/journal.pone.0021222.g008
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placenta of genes involved in modulating chromatin structure in
rather short delays and genes modifying chemically and covalently
the DNA by methylation and thus for longer delays and heritable
modifications, is much less problematic owing to the transient
nature of the placenta. One peculiar category of genes regulated
by epigenetic means is imprinted genes. We show here that these
genes are statistically different from the rest of the genome in the
kidney where there is an excess of upregulated imprinted genes,
and to a lesser extent in the placenta where there is a lack of down-
regulated imprinted genes. In the placenta, alterations of
imprinting are known to impact normal function. For instance,
it has recently been shown in mouse models that a partial
reduction of Ascl2 expression results in severe structure anomalies
of the placenta [54]. Similar observations were seen for Phlda2. In
addition, numerous reports mention alterations of methylation and
expression of H19 and IGF2 in IUGR [31,55,56]. Our own results
reveal different imprinted genes that are altered at the expression
level in the placenta, which may overall contribute to the
deregulation of the ‘imprinted gene network’ at work in this
organ [57].
In an attempt to define hierarchy of the factors that are
modified in IUGR, we used a statistical approach aiming at
identifying statistical differences between the occurrence of
transcription factors binding sites according to the genes that are
modified. This approach has previously be used successfully
[10,58]. In the additional organs studied here, only the liver
revealed such a deviation between induced and repressed genes.
Interestingly in this organ HNF4A binding sites were overrepre-
sented in down-regulated genes. This transcription factor plays an
important role in weight regulation and insulin signaling [59],
especially by regulating apolipoprotein promoters [60]. It is thus
tempting to suggest that in IUGR, deregulations of genes in the
liver passes through this HNF4/fat/insulin pathway.
In summary of the present study, we can assume that gene
alteration expression in the IUGR model contribute to the
possibility of modifying long-term disease risk associated with
unbalanced nutrition in fetal life.
Supporting Information
Figure S1 Correlation between qPCR and microarray data for
the comparison between IUGR and normal rat fetuses for lungs
liver and heart. The log2 of the induction ratio for que qPCR was
presented in abscissa and the log2 of the induction ratio for the
microarray in ordinate. The coefficient of determination of the
linear regression (R
2) is given for each organ.
(PPTX)
Figure S2 Pathways identified by Genomatix as encompassing
modified genes in the placenta; A=VEGFR1 specific signals,
B=EGFR1 signalling, C=Ataxia telangectasia signaling pathway.
Color code is function of the intensity of modification: blue for
down-regulated genes, red for up-regulated genes, orange: not
modified, and grey genes in the cascade but not modified in
IUGR.
(PPTX)
Figure S3 Pathways encompassing genes modified in the heart
in IUGR pups (color codes as in Figure S2). A: FOXA2 and
FOXA3 networks; B: FOXA1 transcription factor network, C:
Hedgehog signaling network. Below the table indicates the p-
values for the enrichment.
(PPTX)
Figure S4 Pathways encompassing genes modified in the liver in
IUGR pups (color codes as in Figure S2). A: Negative regulation of
GDP-GTP exchange signaling, B: Heteromeric GPCR signaling
pathway.
(PPTX)
Figure S5 Pathways encompassing genes modified in the lungs
in IUGR pups (color codes as in Figure S2). A: Regulation of
GDP-GTP exchange signaling, B: IL-7 signaling.
(PPTX)
Figure S6 Non-supervised hierarchical classification of gene
expression in the various tissues analyzed in the study. The
clustering correctly assembles the different tissues, and generally
contrasts correctly the IUGR versus normal condition, except for
lungs where the number of modified transcripts is so high (,34%)
that IUGR and normal are separated from all the other clusters.
(PPTX)
Table S1 List of epigenetic regulators and their degree of
alterations by induced IUGR in the rat model.
(PPTX)
Table S2 List of imprinted genes and their degree of
transcriptional modification by induced IUGR in the rat model.
(PPTX)
Table S3 Body weight, placenta, liver, lung, heart and kidney
weights and number of nephrons in low protein group (LP) and in
control pups group (C).
(PPTX)
Material S1 Organ per organ analysis of pathways enriched in
modified genes in the various organs under scrutiny.
(DOC)
Author Contributions
Conceived and designed the experiments: DV IL IG SB US CB.
Performed the experiments: DV GG-L FB FM J-MF CB. Analyzed the
data: DV US CB. Contributed reagents/materials/analysis tools: CB US
VA. Wrote the paper: DV SB US CB EG.
References
1. Ashworth A (1998) Effects of intrauterine growth retardation on mortality and
morbidity in infants and young children. Eur J Clin Nutr 52 Suppl 1: S34–41;
discussion S41-32.
2. Grantham-McGregor SM (1998) Small for gestational age, term babies, in the
first six years of life. Eur J Clin Nutr 52 Suppl 1: S59–64.
3. Barker DJ (1998) In utero programming of chronic disease. Clin Sci (Lond) 95:
115–128.
4. ACOG (2001) Intrauterine growth restriction. Clinical management guidelines
for obstetrician-gynecologists. American College of Obstetricians and Gynecol-
ogists. Int J Gynaecol Obstet 72: 85–96.
5. Combs CA, Jaekle RK, Rosenn B, Pope M, Miodovnik M, et al. (1993)
Sonographic estimation of fetal weight based on a model of fetal volume. Obstet
Gynecol 82: 365–370.
6. Gardosi J (2011) Clinical strategies for improving the detection of fetal growth
restriction. Clin Perinatol 38: 21–31, v.
7. Richardus JH, Graafmans WC, Verloove-Vanhorick SP, Mackenbach JP (2003)
Differences in perinatal mortality and suboptimal care between 10 European
regions: results of an international audit. Bjog 110: 97–105.
8. McMillen IC, Robinson JS (2005) Developmental origins of the metabolic
syndrome: prediction, plasticity, and programming. Physiol Rev 85:
571–633.
9. McArdle HJ, Andersen HS, Jones H, Gambling L (2006) Fetal programming:
causes and consequences as revealed by studies of dietary manipulation in rats --
a review. Placenta 27 Suppl A: . pp S56–60.
10. Buffat C, Mondon F, Rigourd V, Boubred F, Bessieres B, et al. (2007) A
hierarchical analysis of transcriptome alterations in intrauterine growth
Differential Impact of IUGR on Fetal Organs
PLoS ONE | www.plosone.org 14 June 2011 | Volume 6 | Issue 6 | e21222restriction (IUGR) reveals common pathophysiological pathways in mammals.
J Pathol 213: 337–346.
11. Snoeck A, Remacle C, Reusens B, Hoet JJ (1990) Effect of a low protein diet
during pregnancy on the fetal rat endocrine pancreas. Biol Neonate 57:
107–118.
12. Langley SC, Jackson AA (1994) Increased systolic blood pressure in adult rats
induced by fetal exposure to maternal low protein diets. Clin Sci (Lond) 86:
217–222; discussion 121.
13. Langley-Evans SC (1996) Intrauterine programming of hypertension in the rat:
nutrient interactions. Comp Biochem Physiol A Physiol 114: 327–333.
14. Langley-Evans SC, Sherman RC, Welham SJ, Nwagwu MO, Gardner DS, et al.
(1999) Intrauterine programming of hypertension: the role of the renin-
angiotensin system. Biochem Soc Trans 27: 88–93.
15. Dahri S, Snoeck A, Reusens-Billen B, Remacle C, Hoet JJ (1991) Islet function
in offspring of mothers on low-protein diet during gestation. Diabetes 40 Suppl
2: 115–120.
16. Merlet-Benichou C, Gilbert T, Muffat-Joly M, Lelievre-Pegorier M, Leroy B
(1994) Intrauterine growth retardation leads to a permanent nephron deficit in
the rat. Pediatr Nephrol 8: 175–180.
17. Resnick O, Miller M, Forbes W, Hall R, Kemper T, et al. (1979) Developmental
protein malnutrition: influences on the central nervous system of the rat.
Neurosci Biobehav Rev 3: 233–246.
18. Rutland CS, Latunde-Dada AO, Thorpe A, Plant R, Langley-Evans S, et al.
(2007) Effect of gestational nutrition on vascular integrity in the murine placenta.
Placenta 28: 734–742.
19. Jansson T, Powell TL (2006) IFPA 2005 Award in Placentology Lecture. Human
placental transport in altered fetal growth does the placenta function as a
nutrient sensor? – a review. Placenta 27 Suppl A: S91–97.
20. Fernandez-Twinn DS, Ozanne SE, Ekizoglou S, Doherty C, James L, et al.
(2003) The maternal endocrine environment in the low-protein model of intra-
uterine growth restriction. Br J Nutr 90: 815–822.
21. Buffat C, Boubred F, Mondon F, Chelbi ST, Feuerstein JM, et al. (2007) Kidney
gene expression analysis in a rat model of intrauterine growth restriction reveals
massive alterations of coagulation genes. Endocrinology 148: 5549–5557.
22. Tosh DN, Fu Q, Callaway CW, McKnight RA, McMillen IC, et al. (2010)
Epigenetics of programmed obesity: alteration in IUGR rat hepatic IGF1
mRNA expression and histone structure in rapid vs. delayed postnatal catch-up
growth. Am J Physiol Gastrointest Liver Physiol 299: G1023–1029.
23. Chelbi ST, Mondon F, Doridot L, Dussour C, Rebourcet R, et al. (2011)
Combination of promoter hypomethylation and PDX1 overexpression leads to
TBX15 decrease in vascular IUGR placentas Epigenetics: in press.
24. Livak K, Schmittgen T (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2-DDCt method. Methods 25: 402–408.
25. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and
display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:
14863–14868.
26. Saldanha AJ (2004) Java Treeview--extensible visualization of microarray data.
Bioinformatics 20: 3246–3248.
27. Fauque P, Ripoche MA, Tost J, Journot L, Gabory A, et al. (2010) Modulation
of imprinted gene network in placenta results in normal development of in vitro
manipulated mouse embryos. Hum Mol Genet 19: 1779–1790.
28. Zeng L, Zhou MM (2002) Bromodomain: an acetyl-lysine binding domain.
FEBS Lett 513: 124–128.
29. Nielsen PR, Nietlispach D, Mott HR, Callaghan J, Bannister A, et al. (2002)
Structure of the HP1 chromodomain bound to histone H3 methylated at lysine
9. Nature 416: 103–107.
30. Verdel A, Jia S, Gerber S, Sugiyama T, Gygi S, et al. (2004) RNAi-mediated
targeting of heterochromatin by the RITS complex. Science 303: 672–676.
31. Fauque P, Jouannet P, Lesaffre C, Ripoche MA, Dandolo L, et al. (2007)
Assisted Reproductive Technology affects developmental kinetics, H19 Imprint-
ing Control Region methylation and H19 gene expression in individual mouse
embryos. BMC Dev Biol 7: 116.
32. Glaser RL, Ramsay JP, Morison IM (2006) The imprinted gene and parent-of-
origin effect database now includes parental origin of de novo mutations. Nucleic
Acids Res 34: D29–31.
33. Xie YB, Nedumaran B, Choi HS (2009) Molecular characterization of SMILE
as a novel corepressor of nuclear receptors. Nucleic Acids Res 37: 4100–4115.
34. Barker DJ (2002) Fetal programming of coronary heart disease. Trends
Endocrinol Metab 13: 364–368.
35. Schwitzgebel VM, Somm E, Klee P (2009) Modeling intrauterine growth
retardation in rodents: Impact on pancreas development and glucose
homeostasis. Mol Cell Endocrinol 304: 78–83.
36. Struwe E, Berzl G, Schild R, Blessing H, Drexel L, et al. (2010) Microarray
analysis of placental tissue in intrauterine growth restriction. Clin Endocrinol
(Oxf) 72: 241–247.
37. Simmons RA, Templeton LJ, Gertz SJ (2001) Intrauterine growth retardation
leads to the development of type 2 diabetes in the rat. Diabetes 50: 2279–2286.
38. Wolf G (2003) Adult type 2 diabetes induced by intrauterine growth retardation.
Nutr Rev 61: 176–179.
39. Thompson RF, Fazzari MJ, Niu H, Barzilai N, Simmons RA, et al. (5118)
Experimental intrauterine growth restriction induces alterations in DNA
methylation and gene expression in pancreatic islets of rats. J Biol Chem.
40. Gesta S, Bluher M, Yamamoto Y, Norris AW, Berndt J, et al. (2006) Evidence
for a role of developmental genes in the origin of obesity and body fat
distribution. Proc Natl Acad Sci U S A 103: 6676–6681.
41. Galambos C, Demello DE (2008) Regulation of alveologenesis: clinical
implications of impaired growth. Pathology 40: 124–140.
42. Nikolajev K, Koskela H, Korppi M (2008) Birth weight and adult lung function:
a within-pair analysis of twins followed up from birth. World J Pediatr 4:
222–226.
43. Godlewski G, Gaubert-Cristol R, Rouy S, Prudhomme M (1997) Liver
development in the rat and in man during the embryonic period (Carnegie
stages 11-23). Microsc Res Tech 39: 314–327.
44. Fryer AA, Emes RD, Ismail KM, Haworth KE, Mein C, et al. (2011)
Quantitative, high-resolution epigenetic profiling of CpG loci identifies
associations with cord blood plasma homocysteine and birth weight in humans.
Epigenetics 6: 86–94.
45. Chelbi ST, Mondon F, Jammes H, Buffat C, Mignot TM, et al. (2007)
Expressional and epigenetic alterations of placental serine protease inhibitors:
SERPINA3 is a potential marker of preeclampsia. Hypertension 49: 76–83.
46. Chelbi ST, Vaiman D (2008) Genetic and epigenetic factors contribute to the
onset of preeclampsia. Mol Cell Endocrinol 282: 120–129.
47. Lillycrop KA, Slater-Jefferies JL, Hanson MA, Godfrey KM, Jackson AA, et al.
(2007) Induction of altered epigenetic regulation of the hepatic glucocorticoid
receptor in the offspring of rats fed a protein-restricted diet during pregnancy
suggests that reduced DNA methyltransferase-1 expression is involved in
impaired DNA methylation and changes in histone modifications. Br J Nutr 97:
1064–1073.
48. Franco Mdo C, Arruda RM, Dantas AP, Kawamoto EM, Fortes ZB, et al.
(2002) Intrauterine undernutrition: expression and activity of the endothelial
nitric oxide synthase in male and female adult offspring. Cardiovasc Res 56:
145–153.
49. Torrens C, Kelsall CJ, Hopkins LA, Anthony FW, Curzen NP, et al. (2009)
Atorvastatin restores endothelial function in offspring of protein-restricted rats in
a cholesterol-independent manner. Hypertension 53: 661–667.
50. (2000) Report of the National High Blood Pressure Education Program Working
Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183:
S1–S22.
51. Ke X, Lei Q, James SJ, Kelleher SL, Melnyk S, et al. (2006) Uteroplacental
insufficiency affects epigenetic determinants of chromatin structure in brains of
neonatal and juvenile IUGR rats. Physiol Genomics 25: 16–28.
52. Bonasio R, Tu S, Reinberg D. Molecular signals of epigenetic states. Science
330: 612–616.
53. Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a
and Dnmt3b are essential for de novo methylation and mammalian
development. Cell 99: 247–257.
54. Oh-McGinnis R, Bogutz AB, Lefebvre L (2011) Partial loss of Ascl2 function
affects all three layers of the mature placenta and causes intrauterine growth
restriction. Dev Biol 351: 277–286.
55. Bourque DK, Avila L, Penaherrera M, von Dadelszen P, Robinson WP (2010)
Decreased placental methylation at the H19/IGF2 imprinting control region is
associated with normotensive intrauterine growth restriction but not preeclamp-
sia. Placenta 31: 197–202.
56. Koukoura O, Sifakis S, Zaravinos A, Apostolidou S, Jones A, et al. (2011)
Hypomethylation along with increased H19 expression in placentas from
pregnancies complicated with fetal growth restriction. Placenta 32: 51–57.
57. Varrault A, Gueydan C, Delalbre A, Bellmann A, Houssami S, et al. (2006) Zac1
regulates an imprinted gene network critically involved in the control of
embryonic growth. Dev Cell 11: 711–722.
58. Batista F, Vaiman D, Dausset J, Fellous M, Veitia RA (2007) Potential targets of
FOXL2, a transcription factor involved in craniofacial and follicular
development, identified by transcriptomics. Proc Natl Acad Sci U S A 104:
3330–3335.
59. De Souza CT, Frederico MJ, da Luz G, Cintra DE, Ropelle ER, et al. (2010)
Acute exercise reduces hepatic glucose production through inhibition of the
Foxo1/HNF-4alpha pathway in insulin resistant mice. J Physiol 588:
2239–2253.
60. Ceccarelli V, Nocentini G, Riccardi C, Ayroldi E, Di Nardo P, et al. (2011)
Effect of dietary saturated fatty acids on HNF-4alpha DNA binding activity and
ApoCIII mRNA in sedentary rat liver. Mol Cell Biochem 347: 29–39.
Differential Impact of IUGR on Fetal Organs
PLoS ONE | www.plosone.org 15 June 2011 | Volume 6 | Issue 6 | e21222